Computer Science · Artificial Intelligence
Elimination of Antiestrogenic Effects of Active Tamoxifen
Metabolites Glucuronidation, Yan Zheng, Dongxiao Sun, Arun K. Sharma, Gang Chen, Shantu Amin, Philip Lazarus
See on the mapAbstract
moxifen, TAM) is a nonsteroidal antiestrogen that has been com-monly used for the prevention and treatment of estrogen receptor-positive breast cancer. TAM is extensively metabolized into several primary activemetabolites including 4-hydroxy-TAM (4-OH-TAM) and endoxifen. Glucuronidation is the major phase II metabolic pathway important in their excretion. Whereas high antiestrogenic activity has been reported for both 4-OH-TAM and endoxifen, studies examining the effect of glucuronide conjugation of these metabolites have not previously been performed. In the present study, the antiestrogenic activities of glucuronidated TAM metabolites were determined by examining their effect on the induction of the estrogen-responsive progesterone receptor (PGR) gene. 17-Estradiol (E2)-mediated PGR gene expression in MCF-7 cells was determined by real-time reverse transcriptase-polymerase chain reaction for each TAM metabolite isomer. E2 (1 10